LENALIMIDE 25

Description

Lenalidomide 25mg LENALIMIDE 25 is a prescription-only medicine containing Lenalidomide 25mg, a potent immunomodulatory agent widely used in the management of certain blood cancers and bone marrow disorders. Lenalidomide belongs to a class of drugs related to thalidomide but offers improved efficacy and safety. It is particularly effective in treating multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma (MCL). By enhancing immune system activity, inhibiting the growth of cancer cells, and reducing abnormal blood cell formation, LENALIMIDE 25 helps improve survival outcomes and quality of life in patients suffering from these conditions. Composition and Mechanism of Action Active Ingredient: Lenalidomide 25mg How it Works: Immunomodulatory Action: Enhances the immune system’s ability to detect and destroy abnormal or malignant cells. Antiangiogenic Effect: Inhibits the formation of new blood vessels that supply nutrients to cancer cells. Direct Anti-tumor Action: Prevents proliferation of cancerous cells in the bone marrow. Hematopoietic Support: Reduces abnormal blood cell production in disorders like MDS. This multi-mechanism approach makes LENALIMIDE 25 a powerful agent in both oncology and hematology. Key Benefits Multiple Myeloma: Used in combination therapy to improve patient survival and reduce disease progression. Myelodysplastic Syndromes (MDS): Helps manage anemia by reducing the need for blood transfusions. Mantle Cell Lymphoma (MCL): Provides effective treatment for relapsed or refractory cases. Immunomodulation: Strengthens the immune system’s ability to fight cancer. Oral Convenience: Available in capsule form for easy administration. Indications LENALIMIDE 25 is prescribed for: Multiple Myeloma (MM) – in combination with other anticancer drugs Myelodysplastic Syndromes (MDS) associated with deletion 5q chromosomal abnormality Mantle Cell Lymphoma (MCL) in patients with relapsed or refractory disease Other conditions as determined by oncologists/hematologists Dosage and Administration Typical Adult Dose: 25mg once daily, usually in 21-day treatment cycles, followed by a 7-day rest period. Route: Oral – swallow the capsule whole with water. Important Notes: Dosage may vary depending on the patient’s condition, response to therapy, and combination drugs used. Close monitoring of blood counts and organ function is essential during therapy. Treatment should only be initiated and supervised by a qualified oncologist or hematologist. Safety Information Contraindications: Pregnancy and breastfeeding (Lenalidomide can cause severe birth defects) Hypersensitivity to Lenalidomide or related compounds Precautions: Effective contraception must be used by both men and women during treatment and for some time after discontinuation. Regular blood tests are necessary to monitor white blood cells, platelets, and hemoglobin. Use with caution in patients with kidney or liver impairment. Possible Side Effects: Fatigue, dizziness, or headache Nausea, diarrhea, or constipation Low blood cell counts (anemia, neutropenia, thrombocytopenia) Skin rash or itching Risk of blood clots (thrombosis) in some patients Seek immediate medical help if severe allergic reactions, chest pain, breathing difficulty, or unusual bleeding occur. Storage Store at room temperature (15–25°C) in a dry place. Protect from direct sunlight and moisture. Keep out of reach of children and unauthorized persons. Why Choose LENALIMIDE 25 Clinically proven therapy for blood cancers and related disorders Multi-action mechanism – immunomodulatory, antiangiogenic, and anti-tumor Improves survival rates and quality of life in patients with multiple myeloma and MDS Trusted oncology brand with effective results in combination therapy Oral capsule format ensures patient convenience and compliance Conclusion LENALIMIDE 25 (Lenalidomide 25mg Capsules) is a cornerstone therapy in the management of multiple myeloma, mantle cell lymphoma, and myelodysplastic syndromes. Its targeted action against abnormal cells, combined with its immunomodulatory effects, makes it a highly effective and widely prescribed medication in oncology. With proper medical supervision, LENALIMIDE 25 offers patients a better chance at disease control, improved survival, and enhanced quality of life.